
Christopher Bowlus
Chief, Division of Gastroenterology and Hepatology · University of California Davis Health
Credentials: · · ·
History
- Present
Division of Gastroenterology and Hepatology · University of California Davis Health
- Present
Division Chief · University of California Davis Health
- Present
Division of Gastroenterology and Hepatology · UC Davis Health
1993–1996
- 1985
Research
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
New England Journal of Medicine · 2016 · 940 citations
Hepatology · 2019 · 717 citations
Current Medical Research and Opinion · 2008 · 549 citations

59 papers

54 papers

27 papers

23 papers

21 papers
- MT
18 papers
- JV
16 papers
- KL
14 papers
Grants
- 2014–2017
An Open-Label Study of Ursolkc Acid for Primary Sclerosing Cholangitis
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $410.2K · University of California at Davis
- 2014–2016
Sacramento Collaborative to Advance Testing and Care of Hepatitis b (Scratch)
NCHHSTP · U51
Contact PI · $626.7K · University of California at Davis
- 2013–2016
Biologic Basis of Disparity in Liver Cancer Survival Among Asian Americans
National Cancer Institute · R21
Contact PI · $365.3K · University of California at Davis
- 2001–2003
Oxidative mutagenesis:Iron, Ascorbic Acid and Genes
National Institute of Environmental Health Sciences · R03
Contact PI · $148.3K · University of California at Davis
Clinical trials
- 2022–2026
Principal investigator · Completed · Phase 1, Phase 2
COUR Pharmaceutical Development Company, Inc.
- 2018–2022
Cholangioscopy in Primary Sclerosing Cholangitis (PSC)
Principal investigator · Completed
Boston Scientific Corporation
- 2017–2019
A Study Of Ursolic Acid For Primary Sclerosing Cholangitis
Principal investigator · Withdrawn · Phase 1
University of California, Davis
- 2015–2019
Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients
Principal investigator · Completed
University of California, Davis



